ProKidney Corp (PROK) Implied Volatility Current

Tracking PROK implied volatility helps you identify when options premiums on ProKidney Corp are historically cheap or expensive, and where the best trades are hiding. ProKidney Corp implied volatility reflects the market's expectation of future price movement: when PROK IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor ProKidney Corp's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For PROK, tracking metrics like PROK IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on PROK signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

ProKidney Corp., a clinical-stage biotechnology, engages in developing cellular therapy candidates. It is developing Renal Autologous Cell Therapy, an autologous homologous cell admixture that is in a Phase III development program, as well as Phase II clinical trials for the treatment of moderate to severe diabetic kidney disease; and Phase I clinical trial for patients with congenital anomalies of the kidney and urinary tract. The company was founded in 2015 and is headquartered in Winston-Salem, North Carolina.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where PROK implied volatility sits today versus where it has been. Our scanner ranks ProKidney Corp implied volatility against its historical range, surfaces extremes in PROK IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether ProKidney Corp IV is rich or cheap — measure it, then act on it.